Research analysts at Wolfe Research initiated coverage on shares of Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) in a research note issued to investors on Wednesday, Marketbeat Ratings reports. The firm set an "outperform" rating and a $42.00 price target on the stock. Wolfe Research's price target would indicate a potential upside of 20.72% from the stock's previous close.
A number of other brokerages have also commented on KDP. Deutsche Bank raised their price objective on Keurig Dr Pepper from $30.00 to $32.00 and gave the stock a "hold" rating in a research report on Friday, August 7th. Barclays upped their target price on Keurig Dr Pepper from $38.00 to $41.00 and gave the company an "overweight" rating in a report on Thursday, November 5th. BNP Paribas Exane increased their price target on shares of Keurig Dr Pepper from $28.00 to $29.00 and gave the stock a "neutral" rating in a research report on Monday, August 10th. Piper Sandler restated an "overweight" rating on shares of Keurig Dr Pepper in a report on Wednesday, October 14th. Finally, Citigroup raised their price target on shares of Keurig Dr Pepper from $37.00 to $40.00 and gave the stock a "buy" rating in a report on Wednesday, November 4th. Eleven research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $37.56.
Read Our Latest Research Report on KDP
Keurig Dr Pepper Trading Down 2.2%
Keurig Dr Pepper stock opened at $34.79 on Wednesday. The company has a 50 day moving average price of $33.44 and a 200 day moving average price of $30.52. Keurig Dr Pepper has a 52 week low of $24.88 and a 52 week high of $38.28. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.32 and a current ratio of 0.52. The firm has a market capitalization of $47.35 billion, a price-to-earnings ratio of 31.92, a P/E/G ratio of 1.73 and a beta of 0.35.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last announced its earnings results on Tuesday, November 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.62 by $0.04. The company had revenue of $7.34 billion for the quarter, compared to the consensus estimate of $7.33 billion. Keurig Dr Pepper had a net margin of 7.12% and a return on equity of 11.27%. The company's revenue was up 70.6% on a year-over-year basis. During the same period in the previous year, the business earned $0.54 EPS. Research analysts forecast that Keurig Dr Pepper will post 2.31 EPS for the current year.
Insider Buying and Selling at Keurig Dr Pepper
In other news, Director Aaron Alt bought 7,862 shares of the company's stock in a transaction on Tuesday, August 25th. The shares were bought at an average cost of $31.83 per share, with a total value of $250,247.46. Following the transaction, the director directly owned 7,862 shares in the company, valued at approximately $250,247.46. This trade represents a ∞ increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Angela Stephens sold 9,500 shares of the firm's stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $32.70, for a total value of $310,650.00. Following the sale, the vice president directly owned 55,786 shares of the company's stock, valued at $1,824,202.20. This trade represents a 14.55% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.34% of the company's stock.
Hedge Funds Weigh In On Keurig Dr Pepper
Several hedge funds and other institutional investors have recently added to or reduced their stakes in KDP. Legal & General Group Plc bought a new position in Keurig Dr Pepper during the second quarter worth about $269,336,000. Lone Peak Global Investors LLC boosted its holdings in Keurig Dr Pepper by 6.2% during the second quarter. Lone Peak Global Investors LLC now owns 1,098,204 shares of the company's stock valued at $35,944,000 after purchasing an additional 63,646 shares in the last quarter. Moore Capital Management LP acquired a new stake in Keurig Dr Pepper during the second quarter valued at approximately $10,584,000. Saudi Central Bank grew its stake in shares of Keurig Dr Pepper by 89.7% in the 2nd quarter. Saudi Central Bank now owns 90,351 shares of the company's stock valued at $2,957,000 after purchasing an additional 42,712 shares during the period. Finally, Nykredit A S bought a new stake in shares of Keurig Dr Pepper in the 2nd quarter valued at approximately $8,341,000. Institutional investors own 93.99% of the company's stock.
Keurig Dr Pepper Company Profile
(
Get Free Report)
Keurig Dr Pepper Inc. NASDAQ: KDP is a beverage company that operates across coffee and packaged beverages. Its portfolio includes soft drinks, flavored waters, juices, juice drinks, ready-to-drink teas and coffees, sports and energy beverages, and mixers, as well as single-serve coffee brewing systems and pods. The company’s brands include Keurig, Green Mountain Coffee Roasters, The Original Donut Shop, Dr Pepper, Canada Dry, Snapple, 7UP, A&W, Mott’s, Bai, CORE Hydration and Venom, among others.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.